Skip to main content
. Author manuscript; available in PMC: 2020 Oct 4.
Published in final edited form as: Clin Infect Dis. 2020 Feb 14;70(5):907–916. doi: 10.1093/cid/ciz263

Figure 1.

Figure 1.

Features and Conditions of the Shorter Multidrug-resistant Tuberculosis (MDR-TB) Treatment Regimen

a Kanamycin is not used, and prothionamide is not available in the United States; ethionamide (ETA) is considered bio-equivalent by many, but could have some differences.

b Gatifloxacin was used instead of moxifloxacin in the initial clinical studies.